Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Formulary Restrictions and Stroke Risk in Patients With Atrial Fibrillation
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Formulary Restrictions and Stroke Risk in Patients With Atrial Fibrillation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Stroke Risk
100%
Atrial Fibrillation
100%
Non-vitamin K Antagonist Oral Anticoagulants
100%
Formulary Restriction
100%
Anticoagulant Use
50%
Health Outcomes
33%
Transient Ischemic Attack
33%
Health Impact
16%
Mortality Risk
16%
Anticoagulants
16%
Systemic Embolism
16%
Death Rate
16%
Formulary
16%
Medicare Beneficiaries
16%
Long Delay
16%
Longitudinal Cohort Study
16%
Adverse Health Outcomes
16%
Cox Proportional Hazards Model
16%
Prior Authorization
16%
Medicare Part D
16%
Step Therapy
16%
Restricted Access
16%
Pharmacy Benefit Manager
16%
Patient Access
16%
Underuse
16%
Incident Diagnosis
16%
New-onset Atrial Fibrillation
16%
Aggregate Risk
16%
Medicine and Dentistry
Apoplexy
100%
Atrial Fibrillation
100%
Antithrombotic
100%
Health Outcomes
42%
Medicare
28%
Transient Ischemic Attack
28%
Proportional Hazards Model
14%
Anticoagulant
14%
Drug Therapy
14%
Cohort Analysis
14%
Step Therapy
14%